The increased levels of the chemokine eotaxin in CTC negative patients with the best OS and DFS outcome on the other hand, suggests that the overexpression in tumor cells inhibits CTCs entering the peripheral blood, thus emphasizing a significant anti-angiogenic effect, inhibiting tumor growth and metastasis. Here, CCL11 is linked to neoplasm.